SBPH Average Annual Return Since 2016
Growth of $10,000.00
Without Dividends Reinvested Into SBPH


Also see:
SBPH stock yearly return 2017
SBPH stock yearly return 2018
SBPH stock yearly return 2019
SBPH stock yearly return 2020
SBPH YTD return
Compare SBPH average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 05/06/2016
End date: 11/20/2020
Start price/share: $11.10
End price/share: $1.21
Dividends collected/share: $0.00
Total return: -89.10%
Average Annual Total Return: -38.59%
Starting investment: $10,000.00
Ending investment: $1,090.19
Years: 4.55


SBPH average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Spring Bank Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the discovery and development of a class of therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers using its small molecule nucleotide platform. Co. is developing its product candidate, inarigivir soproxil (inarigivir), for the treatment of chronic hepatitis B virus. Co. has designed its antiviral product candidates, including inarigivir, to selectively activate within infected hepatic cells the cellular protein, retinoic acid-inducible gene 1, to inhibit viral replication and to cause the induction of intracellular interferon signaling pathways for antiviral defense. The SBPH average annual return since 2016 is shown above.

The Average Annual Return on the SBPH average annual return since 2016 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether SBPH average annual return since 2016 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the SBPH average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for SBPH:
SBPH SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
SBPH (SBPH) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

SCPH Average Annual Return
SCYX Average Annual Return
SELB Average Annual Return
SEM Average Annual Return
SGEN Average Annual Return
SGMO Average Annual Return
SGRY Average Annual Return
SGYP Average Annual Return
SIEN Average Annual Return
SIGA Average Annual Return
More Healthcare companies »

 

SBPH Average Annual Return Since 2016 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.